Stay updated on Zephyrus I Clinical Trial
Sign up to get notified when there's something new on the Zephyrus I Clinical Trial page.

Latest updates to the Zephyrus I Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check21 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a Phase 3 trial for pamrevlumab in treating Idiopathic Pulmonary Fibrosis (IPF), including key inclusion and exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference17%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check71 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.8%
Stay in the know with updates to Zephyrus I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus I Clinical Trial page.